Serum interleukin-6 levels in colorectal cancer patients-a summary of published results

International Journal of Colorectal Disease

Volumn 25, Issue 2, 2010, Pages 135-140

  Knüpfer, Heike ^a   Preiss, Rainer ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Colon cancer; IL 6; Prognostic factor

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON CARCINOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR VOLUME;

COLORECTAL NEOPLASMS; HUMANS; INTERLEUKIN-6; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77649239393     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0818-8     Document Type: Review

References (32)

1. PC Heinrich I Behrmann S Haan HM Hermanns G Müller-Newen F Schaper 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 1 1 20 10.1042/BJ20030407 1:CAS:528: DC%2BD3sXmtF2hurs%3D 12773095 Review (Pubitemid 37046923)
2. JA Lust KA Donovan MP Kline PR Greipp RA Kyle NJ Maihle 1992 Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor Cytokine 4 96 100 10.1016/1043-4666(92)90043-Q 1:CAS:528:DyaK2cXivFSnug%3D%3D 1633265
3. S Rose-John GH Waetzig J Scheller J Grötzinger D Seegert 2007 The IL-6/sIL-6R complex as a novel target for therapeutic approaches Expert Opin Ther Targets 11 613 624 10.1517/14728222.11.5.613 1:CAS:528:DC%2BD2sXkslCltbs%3D 17465721 (Pubitemid 46730080)
4. K Althoff J Mullberg D Aasland N Voltz K Kallen J Grotzinger S Rose-John 2001 Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins Biochem J 353 Pt 3 663 672 10.1042/0264-6021:3530663 1:CAS:528:DC%2BD3MXhtlOrtr4%3D 11171064 (Pubitemid 32158335)
5. T Taga M Hibi Y Hirata K Yamasaki K Yasukawa T Matsuda T Hirano T Kishimoto 1989 Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 Cell 58 573 581 10.1016/0092-8674(89)90438-8 1:CAS:528:DyaL1MXlsFWksLg%3D 2788034 (Pubitemid 19203542)
6. A Mackiewicz H Schooltink PC Heinrich S Rose-John 1992 Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins J Immunol 149 2021 2027 1:CAS:528:DyaK3sXitVKrug%3D%3D 1381393
7. S Rose-John H Schooltink 2007 Cytokines are a therapeutic target for the prevention of inflammation-induced cancers Recent Results Cancer Res 174 57 66 10.1007/978-3-540-37696-5-5 1:CAS:528:DC%2BD2sXjvFSgt78%3D 17302185
8. T Hirano K Ishihara M Hibi 2000 Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors Oncogene 19 2548 2556 10.1038/sj.onc.1203551 1:CAS:528:DC%2BD3cXktVGhsbY%3D 10851053
9. CW Schindler 2002 Series introduction. JAK-STAT signaling in human disease J Clin Invest 109 1133 1137 1:CAS:528:DC%2BD38XjsFalsL4%3D 11994400
10. JF Bromberg MH Wrzeszczynska G Devgan Y Zhao RG Pestell C Albanese JE Darnell Jr 1999 Stat3 as an oncogene Cell 98 295 303 10.1016/S0092-8674(00) 81959-5 1:CAS:528:DyaK1MXlt1Cgt7s%3D 10458605 (Pubitemid 29380565)
11. MR Schneider A Hoeflich JR Fischer E Wolf B Sordat H Lahm 2000 Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells Cancer Lett 151 31 38 10.1016/S0304-3835(99)00401-2 1:CAS:528:DC%2BD3cXitFKrt70%3D 10766420 (Pubitemid 30155582)
12. CP Hsu YC Chung 2006 Influence of interleukin-6 on the invasiveness of human colorectal carcinoma Anticancer Res 26 4607 4614 1:CAS:528: DC%2BD2sXpslGgtQ%3D%3D 17201185
13. W Brozek G Bises T Girsch HS Cross HE Kaiser M Peterlik 2005 Differentiation-dependent expression and mitogenic action of interleukin-6 in human colon carcinoma cells: relevance for tumour progression Eur J Cancer 41 2347 2354 10.1016/j.ejca.2005.07.014 1:CAS:528:DC%2BD2MXhtVynurfL 16176872 (Pubitemid 41415612)
14. W Brozek G Bises G Fabjani HS Cross M Peterlik 2008 Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells BMC Cancer 8 13 10.1186/1471-2407-8-13 18205904 (Pubitemid 351315044)
15. C Becker MC Fantini S Wirtz A Nikolaev HA Lehr PR Galle S Rose-John MF Neurath 2005 IL-6 signaling promotes tumor growth in colorectal cancer Cell Cycle 4 217 220 1:CAS:528:DC%2BD28XjtVeru7g%3D 15655344
16. C Becker MC Fantini C Schramm HA Lehr S Wirtz A Nikolaev J Burg S Strand R Kiesslich S Huber H Ito N Nishimoto K Yoshizaki T Kishimoto PR Galle M Blessing S Rose-John MF Neurath 2004 TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 491 501 10.1016/j.immuni.2004.07.020 1:CAS:528:DC%2BD2cXpvVygt7c%3D 15485627 (Pubitemid 39370505)
17. G Galizia M Orditura C Romano E Lieto P Castellano L Pelosio V Imperatore G Catalano C Pignatelli F De Vita 2002 Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery Clin Immunol 102 169 178 10.1006/clim.2001.5163 1:CAS:528:DC%2BD38XisFWmtLk%3D 11846459 (Pubitemid 34171516)
18. V Dymicka-Piekarska J Matowicka-Karna M Gryko I Kemona-Chetnik H Kemona 2007 Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer Thromb Res 20 585 590 10.1016/j.thromres.2006.11.002 (Pubitemid 47094903)
19. T Kinoshita H Ito C Miki 1999 Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma Cancer 85 2526 2531 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2- 3 1:STN:280:DyaK1MzgtFKgtg%3D%3D 10375098 (Pubitemid 29272736)
20. YC Chung YF Chang 2003 Serum interleukin-6 levels reflect the disease status of colorectal cancer J Surg Oncol 83 222 226 10.1002/jso.10269 12884234 (Pubitemid 36936007)
21. T Ueda E Shimada T Urakawa 1994 Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis J Gastroenterol 29 423 429 10.1007/BF02361238 1:STN:280:DyaK2M%2FjvFGnuw%3D%3D 7951851 (Pubitemid 24262709)
22. NI Nikiteas N Tzanakis M Gazouli G Rallis K Daniilidis G Theodoropoulos A Kostakis G Peros 2005 Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications World J Gastroenterol 11 1639 1643 1:CAS:528:DC%2BD2MXjvFOrtb0%3D 15786541
23. J Kaminska MP Nowacki M Kowalska A Rysinska M Chwalinski M Fuksiewicz W Michalski M Chechlinska 2005 Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I-an independent prognostic factor Tumour Biol 26 186 194 10.1159/000086951 1:CAS:528:DC%2BD2MXpvVSmsLg%3D 16006772 (Pubitemid 41379744)
24. F Esfandi S Mohammadzadeh Ghobadloo G Basati 2006 Interleukin-6 level in patients with colorectal cancer Cancer Lett 244 76 78 10.1016/j.canlet.2005.12. 003 1:CAS:528:DC%2BD28XhtVGit7fF 16442710 (Pubitemid 44485868)
25. C Belluco D Nitti M Frantz P Toppan D Basso M Plebani M Lise JM Jessup 2000 Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer Ann Surg Oncol 7 133 138 10.1007/s10434-000-0133-7 1:STN:280:DC%2BD3c3it1Chuw%3D%3D 10761792
26. J Kaminska MM Kowalska MP Nowacki MG Chwalinski A Rysinska M Fuksiewicz 2000 CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients Pathol Oncol Res 6 38 41 10.1007/BF03032656 1:CAS:528: DC%2BD3cXjslSrtr4%3D 10749586
27. T Rich PF Innominato J Boerner MC Mormont S Iacobelli B Baron C Jasmin F Levi 2005 Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer Clin Cancer Res 11 1757 1764 10.1158/1078-0432.CCR- 04-2000 1:CAS:528:DC%2BD2MXitVKrsrk%3D 15755997 (Pubitemid 40471837)
28. H Knupfer R Preiss 2007 Significance of interleukin-6 (IL-6) in breast cancer (review) Breast Cancer Res Treat 102 129 135 10.1007/s10549-006-9328-3 16927176 (Pubitemid 46452175)
29. D Fishman G Faulds R Jeffery V Mohamed-Ali JS Yudkin S Humphries P Woo 1998 The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1369 1376 10.1172/JCI2629 1:CAS:528:DyaK1cXmsFOrsrY%3D 9769329
30. LA Hefler C Grimm S Ackermann S Malur AR Radjabi-Rahat S Leodolter MW Beckmann R Zeillinger H Koelbl CB Tempfer 2003 An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer Cancer Res 63 3066 3068 1:CAS:528:DC%2BD3sXks1eitLg%3D 12810629
31. C Belluco F Olivieri M Bonafè S Giovagnetti E Mammano R Scalerta A Ambrosi C Franceschi D Nitti M Lise 2003 174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer Clin Cancer Res 9 2173 2176 1:CAS:528:DC%2BD3sXksVWqu70%3D 12796383
32. A Tchirkov T Khalil E Chautard K Mokhtari L Véronèse B Irthum P Vago JL Kémény P Verrelle 2007 Interleukin-6 gene amplification and shortened survival in glioblastoma patients Br J Cancer 96 474 476 10.1038/sj.bjc.6603586 1:CAS:528:DC%2BD2sXhtlKjt7g%3D 17224923 (Pubitemid 46215219)